Rapidly Varying Flow
Urodynamic Studies: Uroflowmetry
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
The Buckingham Pi Theorem
Poiseuille's Law and Reynolds Number
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 1, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
David Corcoran1,2, Barry Hennigan1,2, Colin Berry3,4
1West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK.
Fractional flow reserve (FFR) is a diagnostic test used to assess whether a narrowing in a coronary artery is causing reduced blood flow. This article reviews how FFR works, its role in guiding treatment decisions for stable coronary artery disease, and recent developments in its clinical use. FFR measures pressure differences across a stenosis to determine its functional impact. The authors suggest that FFR is a valuable tool in cardiology and should be integrated into routine assessments. They also highlight the expanding role of FFR in various clinical scenarios.
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Area of Science:
Background:
Understanding the functional impact of coronary artery narrowing remains a challenge in cardiology. Prior research has shown that anatomical imaging alone cannot reliably determine whether a blockage causes symptoms. This gap motivated the development of physiological assessment tools like fractional flow reserve (FFR). FFR measures pressure differences across a stenosis to estimate its effect on blood flow. While anatomical imaging is widely used, it lacks the ability to predict functional significance accurately. No prior work had resolved how best to integrate physiological data into routine decision-making. FFR has emerged as a reference standard for evaluating stenoses in stable patients. Yet, its role in broader clinical scenarios remains under investigation. The need for a tool that bridges anatomy and physiology has driven recent advances in FFR measurement.
Purpose Of The Study:
This article aims to evaluate the theoretical and clinical foundations of FFR as a diagnostic tool. The specific problem is determining how to integrate FFR into daily clinical practice for patients with suspected or known coronary artery disease. The motivation stems from the limitations of anatomical imaging in predicting functional outcomes. FFR provides a physiological metric that can guide treatment decisions. The authors seek to clarify the expanding role of FFR in various clinical settings. They also aim to review recent developments in FFR measurement techniques. This work addresses the need for a comprehensive understanding of FFR’s utility in interventional cardiology. By summarizing current evidence, the study supports informed clinical decision-making.
Main Methods:
The authors conducted a review of existing literature on FFR measurement. They analyzed theoretical principles, experimental validations, and clinical applications of FFR. The review approach included evaluating seminal trials that tested FFR-guided interventions. They also examined how FFR is used in stable coronary artery disease. The study incorporates findings from recent trials and clinical guidelines. The authors synthesized evidence on FFR’s role in assessing stenosis severity. They compared FFR with other diagnostic tools to highlight its advantages. The review approach emphasizes FFR’s integration into invasive coronary physiology assessments.
Main Results:
FFR is a reliable method for assessing the functional impact of coronary stenoses. Clinical trials have demonstrated improved outcomes when FFR guides percutaneous coronary interventions. FFR measures pressure gradients across a stenosis to estimate blood flow. It has been validated as a reference standard in stable coronary artery disease. Recent studies suggest expanding FFR’s use to new clinical scenarios. FFR provides a quantitative metric that correlates with patient symptoms. The review highlights FFR’s role in guiding treatment decisions. These findings support the growing adoption of FFR in invasive cardiology.
Conclusions:
The authors propose that FFR is a valuable tool for assessing coronary stenoses in clinical practice. They suggest that FFR-guided interventions improve outcomes in stable coronary artery disease. The review highlights the need for continued research into FFR’s broader applications. The authors propose that FFR should be integrated into routine invasive assessments. They suggest that FFR complements anatomical imaging in decision-making. The review emphasizes FFR’s role in optimizing treatment strategies. The authors propose that FFR is a key component of comprehensive coronary physiology evaluation. These conclusions are based on the synthesized evidence from clinical trials and guidelines.
FFR is an invasive test that measures pressure differences across a coronary stenosis to determine its functional significance. It guides percutaneous coronary interventions in stable disease.
FFR provides a physiological metric, while anatomical imaging shows only the structure. FFR identifies functionally significant stenoses that may not be apparent on imaging.
FFR is used to assess stenosis severity in stable coronary artery disease and is expanding into other clinical scenarios, as suggested by recent trials.
Recent developments include integrating FFR into broader clinical scenarios and refining its role in comprehensive coronary physiology assessments.
FFR is measured using pressure wires during coronary catheterization. It indicates the ratio of maximum achievable blood flow in a stenotic artery to normal flow.
The authors propose that FFR should be integrated into routine invasive assessments to guide treatment decisions in coronary artery disease.